• Bridion 100 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  SUGAMMADEX SODIUM	100 mg

  ATC: V03A V03AB V03AB35

• Bridion 100 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  SUGAMMADEX SODIUM	100 mg

  ATC: V03A V03AB V03AB35

• Cancidas 50 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  CASPOFUNGIN	50 mg

  ATC: J02A J02AX J02AX04

• Cancidas 70 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  CASPOFUNGIN	70 mg

  ATC: J02A J02AX J02AX04

• Capvaxive solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 3	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 7F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 8	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 9N	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 10A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 11A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 12F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 15A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 15B	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 16F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 17F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 20A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 22F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 23A	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 23B	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 24F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 31	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 33F	4 µg/dosis
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 35B	4 µg/dosis

  ATC: J07A J07AL J07AL02

• Cubicin 350 mg powder for solution for injection and for infusion

  Form: powder for injectable solution and for perfusion

  Active substance	Dosage
  DAPTOMYCIN	350 mg

  ATC: J01X J01XX J01XX09

• Cubicin 500 mg powder for solution for injection and for infusion

  Form: powder for injectable solution and for perfusion

  Active substance	Dosage
  DAPTOMYCIN	500 mg

  ATC: J01X J01XX J01XX09

• Efficib 50 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	1000 mg
  SITAGLIPTIN	50 mg

  ATC: A10B A10BD A10BD07

• Emend 125 mg hard capsules / Emend 80 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  APREPITANT	225 mg

  ATC: A04A A04AD A04AD12

• Gardasil 9 suspension for injection in pre-filled syringe

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN	60 µg
  HUMAN PAPILLOMAVIRUS TYPE 6 PROTEIN L1	30 µg
  HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN	40 µg
  HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN	20 µg
  HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN	40 µg
  HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN	20 µg
  HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN	20 µg
  HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN	20 µg
  HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN	20 µg

  ATC: J07B J07BM J07BM03

• HBVaxPro 10 micrograms, injectable suspension in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  Hepatitis B surface antigen	10 µg

  ATC: J07B J07BC J07BC01

• HBVaxPro 40 micrograms, injection suspension

  Form: suspension for injection

  Active substance	Dosage
  Hepatitis B surface antigen	0,04 mg

  ATC: J07B J07BC J07BC01

• HBVaxPro 5 micrograms, suspension for injection in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  Hepatitis B surface antigen	5 µg

  ATC: J07B J07BC J07BC01

• Invanz 1 g powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  ERTAPENEM	1 g

  ATC: J01D J01DH J01DH03

• Isentress 100 mg chewable tablets

  Form: tablets, chewable

  Active substance	Dosage
  RALTEGRAVIR	100 mg

  ATC: J05A J05AJ J05AJ01

• Isentress 25 mg chewable tablets

  Form: tablets, chewable

  Active substance	Dosage
  RALTEGRAVIR	25 mg

  ATC: J05A J05AJ J05AJ01

• Isentress 400 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RALTEGRAVIR	400 mg

  ATC: J05A J05AJ J05AJ01

• Isentress 600 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RALTEGRAVIR	600 mg

  ATC: J05A J05AJ J05AJ01

• Ivemend 150 mg powder for solution for infusion

  Form: powder for solution for infusion

  Active substance	Dosage
  FOSAPREPITANT DIMETHYLGLUCAMINE	150 mg

  ATC: A04A A04AD A04AD12

• Janumet 50 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	1000 mg
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	50 mg

  ATC: A10B A10BD A10BD07

• Januvia 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	100 mg

  ATC: A10B A10BH A10BH01

• Januvia 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	100 mg

  ATC: A10B A10BH A10BH01

• Januvia 25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN	25 mg

  ATC: A10B A10BH A10BH01

• Januvia 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN	50 mg

  ATC: A10B A10BH A10BH01

• Keytruda 25 mg/ml concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  PEMBROLIZUMAB	100 mg

  ATC: L01F L01FF L01FF02

• Lyfnua 45 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  GEFAPIXANT	45 mg

  ATC: R05D R05DB R05DB29

• M-M-RVaxPro powder and solvent for injectable suspension in pre-filled syringe

  Form: powder and solvent for injectable suspension

  Active substance	Dosage
  RUBELLA VIRUS	1 MILES DICT50 VIRUS
  MEASLES VIRUS	1 MILES DICT50 VIRUS
  MUMPS VIRUS	12,5 MILES DICT50 VIRUS

  ATC: J07B J07BD J07BD52

• Noxafil 100 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  POSACONAZOLE	100,0 mg

  ATC: J02A J02AC J02AC04

• Noxafil 300 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  POSACONAZOLE	18 mg

  ATC: J02A J02AC J02AC04

• Noxafil 40 mg/ml oral suspension

  Form: suspension, oral

  Active substance	Dosage
  POSACONAZOLE	40 mg

  ATC: J02A J02AC J02AC04

• Pifeltro 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  DORAVIRINE	100 mg

  ATC: J05A J05AG J05AG06

• Prevymis 240 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LETERMOVIR	240 mg

  ATC: J05A J05AX J05AX18

• Prevymis 480 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  LETERMOVIR	480 mg

  ATC: J05A J05AX J05AX18

• ProQuad powder and solvent for injectable suspension in pre-filled syringe

  Form: powder and solvent for injectable suspension

  Active substance	Dosage
  RUBELLA VIRUS	3 Dosis infectiva 50% en cultivo tisular
  MEASLES VIRUS	3 Dosis infectiva 50% en cultivo tisular
  MUMPS VIRUS	4,3 Dosis infectiva 50% en cultivo tisular
  VARICELLA VIRUS	3,99 U FIP

  ATC: J07B J07BD J07BD54

• Recarbrío 500 mg/500 mg/250 mg powder for solution for infusion

  Form: powder for solution for infusion

  Active substance	Dosage
  IMIPENEM MONOHYDRATE	530 mg
  CILASTATIN SODIUM	531 mg
  RELEBACTAM MONOHYDRATE	263 mg

  ATC: J01D J01DH J01DH56

• Ristaben 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	128,9 mg

  ATC: A10B A10BH A10BH01

• Ristaben 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	128,9 mg

  ATC: A10B A10BH A10BH01

• Ristaben 25 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	32,22 mg

  ATC: A10B A10BH A10BH01

• Ristaben 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	64,44 mg

  ATC: A10B A10BH A10BH01

• Ristfor 50 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	1000 mg
  SITAGLIPTIN PHOSPHATE MONOHYDRATE	50 mg

  ATC: A10B A10BD A10BD07

• Rotateq oral solution

  Form: solution, oral

  Active substance	Dosage
  HUMAN ROTAVIRUS SEROTYPE G2	2,8 U
  HUMAN ROTAVIRUS SEROTYPE G1	2,2 U
  HUMAN ROTAVIRUS SEROTYPE G3	2,2 U
  HUMAN ROTAVIRUS SEROTYPE G4	2 U
  HUMAN ROTAVIRUS SEROTYPE P1	2,3 U

  ATC: J07B J07BH J07BH02

• Segluromet 2.5 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ERTUGLIFLOZIN L-PIROGLUTAMIC ACID	3,238 mg
  METFORMIN HYDROCHLORIDE	1000 mg

  ATC: A10B A10BD A10BD23

• Segluromet 7.5 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ERTUGLIFLOZIN L-PIROGLUTAMIC ACID	9,713 mg
  METFORMIN HYDROCHLORIDE	1000 mg

  ATC: A10B A10BD A10BD23

• Sivextro 200 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TEDIZOLID PHOSPHATE	200 mg

  ATC: J01X J01XX J01XX11

• Sivextro 200 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TEDIZOLID PHOSPHATE	200 mg

  ATC: J01X J01XX J01XX11

• Steglatro 15 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ERTUGLIFLOZIN L-PIROGLUTAMIC ACID	19,431 mg

  ATC: A10B A10BK A10BK04

• Steglatro 5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ERTUGLIFLOZIN L-PIROGLUTAMIC ACID	6,477 mg

  ATC: A10B A10BK A10BK04

• Temodal 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TEMOZOLOMIDE	100 mg

  ATC: L01A L01AX L01AX03

• Temodal 140 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TEMOZOLOMIDE	140 mg

  ATC: L01A L01AX L01AX03

• Temodal 20 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TEMOZOLOMIDE	20 mg

  ATC: L01A L01AX L01AX03